Lori Parsons

5.0k total citations · 1 hit paper
44 papers, 3.6k citations indexed

About

Lori Parsons is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Lori Parsons has authored 44 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Surgery. Recurrent topics in Lori Parsons's work include Acute Myocardial Infarction Research (21 papers), Cardiac Imaging and Diagnostics (12 papers) and Heart Failure Treatment and Management (8 papers). Lori Parsons is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Cardiac Imaging and Diagnostics (12 papers) and Heart Failure Treatment and Management (8 papers). Lori Parsons collaborates with scholars based in United States, United Kingdom and Italy. Lori Parsons's co-authors include Nathan R. Every, Hal V. Barron, Viola Vaccarino, Harlan M. Krumholz, Eric D. Peterson, John G. Canto, William J. French, William J. Rogers, Mark A. Hlatky and W. Douglas Weaver and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Lori Parsons

42 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sex-Based Differences in Early Mortality after Myocardial Infarction

1999 971 citations Viola Vaccarino, Lori Parsons et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori Parsons United States	26	2.5k	955	651	491	355	44	3.6k
Costas T. Lambrew United States	28	4.0k 1.6×	1.2k 1.2×	862 1.3×	365 0.7×	351 1.0×	54	4.8k
Constance K. Haan United States	25	3.3k 1.3×	2.2k 2.3×	477 0.7×	968 2.0×	307 0.9×	35	5.1k
Alan J. Tiefenbrunn United States	26	2.7k 1.1×	1.1k 1.1×	988 1.5×	438 0.9×	203 0.6×	53	3.6k
Jennifer S. Lawton United States	35	2.7k 1.1×	1.4k 1.4×	278 0.4×	783 1.6×	137 0.4×	190	3.9k
Will Weaver United States	11	3.2k 1.3×	1.4k 1.5×	1.2k 1.8×	156 0.3×	321 0.9×	17	4.0k
Mattie Lenzen Netherlands	30	2.8k 1.1×	1.4k 1.5×	790 1.2×	561 1.1×	211 0.6×	121	3.8k
Gordon FitzGerald United States	24	2.0k 0.8×	986 1.0×	326 0.5×	258 0.5×	110 0.3×	45	3.3k
Yves Juillière France	37	3.7k 1.5×	1.2k 1.2×	897 1.4×	790 1.6×	119 0.3×	202	4.8k
David van Klaveren Netherlands	32	2.1k 0.8×	1.8k 1.9×	753 1.2×	650 1.3×	473 1.3×	121	4.5k
Ignacio Ferreira‐González Spain	34	2.4k 1.0×	1.2k 1.2×	474 0.7×	959 2.0×	420 1.2×	201	4.0k

Countries citing papers authored by Lori Parsons

Since Specialization

Citations

This map shows the geographic impact of Lori Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Parsons more than expected).

Fields of papers citing papers by Lori Parsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Parsons. The network helps show where Lori Parsons may publish in the future.

Co-authorship network of co-authors of Lori Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Parsons. A scholar is included among the top collaborators of Lori Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Parsons. Lori Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mauro, Michael J., Rüdiger Hehlmann, Loretta A. Williams, et al.. (2025). Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study – SIMPLICITY. Leukemia & lymphoma. 66(9). 1615–1624. 1 indexed citations

Chung, Leland W.K., Harrison W. Farber, Raymond L. Benza, et al.. (2014). Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry. CHEST Journal. 146(6). 1494–1504. 103 indexed citations

Vaccarino, Viola, Lori Parsons, Eric D. Peterson, et al.. (2009). Sex Differences in Mortality After Acute Myocardial Infarction. Archives of Internal Medicine. 169(19). 1767–74. 172 indexed citations

Peterson, Eric D., Bimal R. Shah, Lori Parsons, et al.. (2008). Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal. 156(6). 1045–1055. 195 indexed citations

Nallamothu, Brahmajee K., Martha Blaney, Lori Parsons, et al.. (2007). Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from 1994-2003. The American Journal of Medicine. 120(8). 693.e1–693.e8. 16 indexed citations

Bromberg‐Marin, Guilherme, José Antônio Marin‐Neto, Lori Parsons, John G. Canto, & William J. Rogers. (2006). Effectiveness and Safety of Glycoprotein IIb/IIIa Inhibitors and Clopidogrel Alone and in Combination in Non–ST-Segment Elevation Myocardial Infarction (from the National Registry of Myocardial Infarction-4). The American Journal of Cardiology. 98(9). 1125–1131. 8 indexed citations

McGuire, Darren K., Amit Khera, James A. de Lemos, et al.. (2004). 827-3 Women with diabetes mellitus have the greatest reduction in myocardial infarction mortality over the past decade: Evaluation of 1,428,596 patients enrolled in the national registry of myocardial infarction 2, 3, and 4 from 1994–2002. Journal of the American College of Cardiology. 43(5). A284–A284. 4 indexed citations

Manhapra, Ajay, John G. Canto, Viola Vaccarino, et al.. (2004). Relation of age and race with hospital death after acute myocardial infarction. American Heart Journal. 148(1). 92–98. 26 indexed citations

Roe, Matthew T., Lori Parsons, Charles V. Pollack, et al.. (2003). Disparities in the treatment of acute myocardial infarction: Underutilization of evidence-based therapies for patients with non-ST-segment myocardial infarction. Journal of the American College of Cardiology. 41(6). 540–541. 1 indexed citations

10.

Grzybowski, Mary, Elizabeth Clements, Lori Parsons, et al.. (2003). Mortality Benefit of Immediate Revascularization of Acute ST-Segment Elevation Myocardial Infarction in Patients With Contraindications to Thrombolytic Therapy. JAMA. 290(14). 1891–1891. 72 indexed citations

11.

Krumholz, Harlan M., Cary P. Gross, Eric D. Peterson, et al.. (2003). Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. American Heart Journal. 146(5). 839–847. 49 indexed citations

12.

Shavelle, David M., et al.. (2002). Is there a benefit to early angiography in patients with ST-segment depression myocardial infarction? An observational study. American Heart Journal. 143(3). 488–496. 9 indexed citations

13.

Wu, Audrey H., Lori Parsons, Nathan R. Every, & Eric Bates. (2002). Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. Journal of the American College of Cardiology. 40(8). 1389–1394. 198 indexed citations

14.

Every, Nathan R., Alfred P. Hallstrom, Kathryn M McDonald, et al.. (2002). Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. American Heart Journal. 144(3). 390–396. 30 indexed citations

15.

Vaccarino, Viola, Lori Parsons, Nathan R. Every, Hal V. Barron, & Harlan M. Krumholz. (2000). Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction. The American Journal of Cardiology. 85(12). 1486–1489. 45 indexed citations

16.

Weaver, W. Douglas, et al.. (1996). Reperfusion therapy after pre-hospital cardiac arrest and its influence on outcome after acute myocardial infarction. Journal of the American College of Cardiology. 27(2). 278–278. 7 indexed citations

17.

Every, Nathan R., Lori Parsons, Mark A. Hlatky, Jenny S. Martin, & W. Douglas Weaver. (1996). A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction. New England Journal of Medicine. 335(17). 1253–1260. 229 indexed citations

18.

Weiner, Donald A., Thomas J. Ryan, Lori Parsons, et al.. (1995). Long-term prognostic value of exercise testing in men and women from the coronary artery surgery study (CASS) registry. The American Journal of Cardiology. 75(14). 865–870. 78 indexed citations

19.

Weiner, Donald A., Thomas J. Ryan, Lori Parsons, et al.. (1991). Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: A report from the Coronary Artery Surgery Study (CASS) randomized population. Journal of the American College of Cardiology. 18(2). 343–348. 46 indexed citations

20.

Weiner, Donald A., Thomas J. Ryan, Lori Parsons, et al.. (1990). The prevalence and prognostic significance of silent myocardial ischemia after coronary bypass surgery. Journal of the American College of Cardiology. 15(2). A119–A119. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact